Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dermofix
2. Dermoseptic
3. Ginedermofix
4. Mykosert
5. Sertaconazole
6. Sertaconazole Mononitrate
7. Zalain
1. 99592-39-9
2. Dermofix
3. Ertaczo
4. Zalain
5. Sertaconazole Mononitrate
6. Ginedermofix
7. Dermovit
8. Fi 7056
9. Sertaconazole (nitrate)
10. Fi-7045
11. 99592-39-9 (nitrate)
12. 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric Acid
13. 1dv05410m5
14. Fi-7056
15. 1-[2-[(7-chloro-1-benzothien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1h-imidazole Nitrate
16. 1h-imidazole, 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, Mononitrate
17. Dermoseptic
18. 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1h-imidazole; Nitric Acid
19. Fisderm
20. Extens
21. Onabet
22. Sr-05000001439
23. Unii-1dv05410m5
24. Sertaconazolenitrate
25. Ertaczo (tn)
26. Zalain (tn)
27. 1-(2-((7-chlorobenzo[b]thiophen-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole Nitrate
28. 1h-imidazole, 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, Nitrate (1:1)
29. Ncgc00016966-01
30. Cas-99592-39-9
31. Dsstox_cid_25529
32. Dsstox_rid_80932
33. Dsstox_gsid_45529
34. Mls002154122
35. Schembl261807
36. Chembl1200725
37. Dtxsid2045529
38. Hy-b0736a
39. Hms1571a12
40. Hms2098a12
41. Hms2231n14
42. Hms3372h01
43. Hms3715a12
44. Sertaconazole Nitrate [mi]
45. Amy32537
46. Bcp09311
47. Tox21_110718
48. Ac-739
49. Fi7056
50. Mfcd00918063
51. S3161
52. Sertaconazole Nitrate [mart.]
53. Akos015888158
54. Akos015964610
55. Sertaconazole Nitrate [who-dd]
56. Ccg-221045
57. 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; Nitric Acid
58. As-14332
59. Smr001233429
60. Sertaconazole Nitrate [orange Book]
61. Sertaconazole Nitrate [ep Monograph]
62. Ft-0674558
63. D08510
64. F20635
65. A846049
66. A851341
67. Sr-05000001439-3
68. Q27252298
69. 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole Mononitrate
70. 1-[2-[(7-chloranyl-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; Nitric Acid
71. 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole,nitric Acid
1. Sertaconazole
2. Sertaconazol
3. Demofix
| Molecular Weight | 500.8 g/mol |
|---|---|
| Molecular Formula | C20H16Cl3N3O4S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 498.992710 g/mol |
| Monoisotopic Mass | 498.992710 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 513 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Ertaczo |
| PubMed Health | Sertaconazole (On the skin) |
| Drug Classes | Antifungal |
| Drug Label | ERTACZO (sertaconazole nitrate) Cream, 2%, contains the imidazole antifungal, sertaconazole nitrate. Sertaconazole nitrate contains one asymmetric carbon atom and exists as a racemic mixture of equal amounts of R and S enantiomers.Sertaconazole nit... |
| Active Ingredient | Sertaconazole nitrate |
| Dosage Form | Cream |
| Route | Topical |
| Strength | 2% |
| Market Status | Prescription |
| Company | Valeant Luxembourg |
| 2 of 2 | |
|---|---|
| Drug Name | Ertaczo |
| PubMed Health | Sertaconazole (On the skin) |
| Drug Classes | Antifungal |
| Drug Label | ERTACZO (sertaconazole nitrate) Cream, 2%, contains the imidazole antifungal, sertaconazole nitrate. Sertaconazole nitrate contains one asymmetric carbon atom and exists as a racemic mixture of equal amounts of R and S enantiomers.Sertaconazole nit... |
| Active Ingredient | Sertaconazole nitrate |
| Dosage Form | Cream |
| Route | Topical |
| Strength | 2% |
| Market Status | Prescription |
| Company | Valeant Luxembourg |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Solubilizers
Controlled & Modified Release
Thickeners and Stabilizers
Granulation
Coating Systems & Additives
Film Formers & Plasticizers
Digital Content
DATA COMPILATION #PharmaFlow
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
87
PharmaCompass offers a list of Sertaconazole Nitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sertaconazole Nitrate manufacturer or Sertaconazole Nitrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sertaconazole Nitrate manufacturer or Sertaconazole Nitrate supplier.
PharmaCompass also assists you with knowing the Sertaconazole Nitrate API Price utilized in the formulation of products. Sertaconazole Nitrate API Price is not always fixed or binding as the Sertaconazole Nitrate Price is obtained through a variety of data sources. The Sertaconazole Nitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAS-99592-39-9 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-99592-39-9, including repackagers and relabelers. The FDA regulates CAS-99592-39-9 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-99592-39-9 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-99592-39-9 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-99592-39-9 supplier is an individual or a company that provides CAS-99592-39-9 active pharmaceutical ingredient (API) or CAS-99592-39-9 finished formulations upon request. The CAS-99592-39-9 suppliers may include CAS-99592-39-9 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-99592-39-9 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CAS-99592-39-9 CEP of the European Pharmacopoeia monograph is often referred to as a CAS-99592-39-9 Certificate of Suitability (COS). The purpose of a CAS-99592-39-9 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CAS-99592-39-9 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CAS-99592-39-9 to their clients by showing that a CAS-99592-39-9 CEP has been issued for it. The manufacturer submits a CAS-99592-39-9 CEP (COS) as part of the market authorization procedure, and it takes on the role of a CAS-99592-39-9 CEP holder for the record. Additionally, the data presented in the CAS-99592-39-9 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CAS-99592-39-9 DMF.
A CAS-99592-39-9 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CAS-99592-39-9 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CAS-99592-39-9 suppliers with CEP (COS) on PharmaCompass.
A CAS-99592-39-9 written confirmation (CAS-99592-39-9 WC) is an official document issued by a regulatory agency to a CAS-99592-39-9 manufacturer, verifying that the manufacturing facility of a CAS-99592-39-9 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting CAS-99592-39-9 APIs or CAS-99592-39-9 finished pharmaceutical products to another nation, regulatory agencies frequently require a CAS-99592-39-9 WC (written confirmation) as part of the regulatory process.
click here to find a list of CAS-99592-39-9 suppliers with Written Confirmation (WC) on PharmaCompass.
CAS-99592-39-9 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-99592-39-9 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-99592-39-9 GMP manufacturer or CAS-99592-39-9 GMP API supplier for your needs.
A CAS-99592-39-9 CoA (Certificate of Analysis) is a formal document that attests to CAS-99592-39-9's compliance with CAS-99592-39-9 specifications and serves as a tool for batch-level quality control.
CAS-99592-39-9 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-99592-39-9 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-99592-39-9 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-99592-39-9 EP), CAS-99592-39-9 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-99592-39-9 USP).
